Citadel Advisors
PDSB icon

Citadel Advisors’s PDS Biotechnology PDSB Stock Holding History

Citadel Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,200
Closed -$1.43K – 14428
2025
Q1 		$1.43K Sell
1,200
-5,500
-82% -$7.82K ﹤0.01% 14131
2024
Q4 		$10.9K Buy
6,700
+600
+10% +$1.59K ﹤0.01% 13575
2024
Q3 		$23.3K Sell
6,100
-38,900
-86% -$130K ﹤0.01% 12660
2024
Q2 		$132K Sell
45,000
-24,900
-36% -$79.7K ﹤0.01% 10530
2024
Q1 		$277K Sell
69,900
-39,100
-36% -$201K ﹤0.01% 9628
2023
Q4 		$542K Buy
109,000
+1,300
+1% +$6.46K ﹤0.01% 7928
2023
Q3 		$544K Buy
107,700
+54,300
+102% +$297K ﹤0.01% 7871
2023
Q2 		$269K Buy
53,400
+32,000
+150% +$210K ﹤0.01% 9281
2023
Q1 		$132K Sell
21,400
-26,800
-56% -$219K ﹤0.01% 10847
2022
Q4 		$636K Buy
48,200
+30,300
+169% +$214K ﹤0.01% 7749
2022
Q3 		$53K Sell
17,900
-71,500
-80% -$303K ﹤0.01% 11584
2022
Q2 		$326K Buy
89,400
+64,200
+255% +$305K ﹤0.01% 9621
2022
Q1 		$156K Sell
25,200
-7,700
-23% -$47.8K ﹤0.01% 11809
2021
Q4 		$266K Sell
32,900
-15,400
-32% -$166K ﹤0.01% 11188
2021
Q3 		$720K Sell
48,300
-50,700
-51% -$632K ﹤0.01% 8995
2021
Q2 		$1.24M Buy
+99,000
New +$773K ﹤0.01% 7770

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors's PDSB Position: Q2 2026 in Review

Citadel Advisors opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 323,801 shares worth $285K. The stake represents ﹤0.01% of the portfolio and ranks #11224 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PDSB as recently as Q3 2025.

Citadel Advisors first reported a position in PDSB in Q1 2018 and has held it in 20 quarters since. The position peaked at $3.26M in Q3 2021. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Citadel Advisors held 323,801 shares of PDS Biotechnology worth $285K as of Q2 2026.
  • PDS Biotechnology was a new Citadel Advisors position in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11224 holding.
  • Citadel Advisors first reported a position in PDS Biotechnology in Q1 2018 and has held it in 20 quarters since.
  • Citadel Advisors's PDS Biotechnology position peaked at $3.26M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.